Expertise in
3
conditions

Xavier Durrmeyer

Université Paris Est Créteil, IMRB, GRC CARMAS, 
Creteil, FR 
Expertise in
3
conditions
Université Paris Est Créteil, IMRB, GRC CARMAS, 
Creteil, FR 

Overview

Xavier Durrmeyer practices practicing medicine in Creteil, France.

Mr. Durrmeyer is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Premature Infant, Patent Ductus Arteriosus, Bronchopulmonary Dysplasia, and Infant Respiratory Distress Syndrome.

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Université Paris Est Créteil, IMRB, GRC CARMAS, Creteil, France
Other Locations
INSERM UMR 1137, INSERM UMR 1123, INSERM UMR 1153, Université Paris Est, Université Paris Est Créteil, Toulouse, France
Val-de-la-haye, 94000, France
Paris, France
Université Paris Est Créteil Val De Marne, Créteil, Irles, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
Enrollment Status: Completed
Publish Date: March 16, 2026
Intervention Type: Drug
Study Drug: Acetaminophen
Study Phase: Phase 2/Phase 3
Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Noninvasive Neurally Adjusted Ventilatory Assist Ventilation in Extremely Premature Infants: a Randomized Crossover Trial
Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Noninvasive Neurally Adjusted Ventilatory Assist Ventilation in Extremely Premature Infants: a Randomized Crossover Trial
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
Study on Preventing Adverse Events in Neonates (SEPREVEN): a Stepped-wedge Randomised Controlled Trial to Reduce Adverse Event Rates in the NICU
Study on Preventing Adverse Events in Neonates (SEPREVEN): a Stepped-wedge Randomised Controlled Trial to Reduce Adverse Event Rates in the NICU
Enrollment Status: Completed
Publish Date: December 29, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
Impact of Early Targeted Ibuprofene Treatment of Patent Ductus Arteriosus (PDA) on Long Term Neurodevelopmental Outcome in Very Premature Infants (TRIOCAPI)
Impact of Early Targeted Ibuprofene Treatment of Patent Ductus Arteriosus (PDA) on Long Term Neurodevelopmental Outcome in Very Premature Infants (TRIOCAPI)
Enrollment Status: Completed
Publish Date: July 08, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

63 Total Publications

A quality improvement study on noise reduction in a level 3 neonatal intensive care unit.
A quality improvement study on noise reduction in a level 3 neonatal intensive care unit.
Journal: European journal of pediatrics
Published: April 08, 2026

Frequently Asked Questions about Xavier Durrmeyer

Is Xavier Durrmeyer a top-rated expert for Premature Infant?

MediFind is an objective health platform that identifies experts based on real-world data. Xavier Durrmeyer is classified as an Distinguished expert for Premature Infant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xavier Durrmeyer participate in research or clinical trials?

Yes. Xavier Durrmeyer has published 63 articles and abstracts on conditions like Premature Infant. You can view a list of Xavier Durrmeyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Durrmeyer's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile